IP Library Granted Patent US 12,702,137
Granted Patent B2
US 12,702,137 · App. 17/686,703 · Granted Aug 11, 2026

Antifungal

Inventor: Renèe Rioux (Morrisville, NC)
Assignee: NewLeaf Symbiotics, Inc.
A01N63/30A01N25/04A01N63/20A01P1/00A01P3/00C12N1/20C12N1/205C12R2001/01C12R2001/26Y02E50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,702,137
App. No.
17/686,703
Filed
Mar 4, 2022
Granted
Aug 11, 2026
Kind
B2
Art Unit
1614
USPC
504/117
Abstract

Compositions comprising Methylobacterium with anti-fungal activity, methods for controlling plant pathogenic fungi, and methods of making the compositions are provided.

Claims (19)

1 . A composition for treating a seed of a leguminous or cereal crop plant susceptible to infection by a fungal pathogen, wherein said composition comprises (a) a Methylobacterium strain selected from the group consisting of NLS0089 (NRRL B-50933) and NLS0066 (NRRL B-50940) and (b) a carrier, wherein said Methylobacterium strain is at a titer of at least 5×10 7 colony-forming units per gram for a dry composition, or at least 5×10 7 colony-forming units per milliliter for a liquid composition, an effective amount for treating the seed of the leguminous or cereal crop plant susceptible to infection by the fungal pathogen.

2 . The composition of claim 1 wherein said composition further comprises an antifungal compound selected from the group consisting of an azole, dithiocarbamate, strobilurin, and benzimidazole.

3 . The composition of claim 2 wherein said azole antifungal compound is ipconazole.

4 . The composition of claim 1 wherein said composition further comprises a fungicide.

5 . The composition of claim 1 wherein said plant is susceptible to infection by the fungal pathogen selected from the group consisting of a Rhizoctonia sp., a Fusarium sp., a Pythium sp., a Septoria sp., a Cercospora sp., a Colletotrichum sp., a Puccinia sp., and a Sclerotinia sp.

6 . The composition of claim 1 wherein said composition further comprises an agricultural polymer solution.

7 . The composition of claim 1 wherein said composition further comprises a second Methylobacterium strain selected from the group consisting of NLS0017 (NRRL B-50931) and NLS0020 (NRRL B-50930).

8 . A method for reducing adverse effects to a plant, wherein said adverse effects are caused by growth of a fungal pathogen, wherein said method comprises applying a composition comprising (a) a Methylobacterium strain selected from the group consisting of NLS0089 (NRRL B-50933) and NLS0066 (NRRL B-50940) and (b) a carrier to a plant or plant part that is susceptible to adverse effects caused by growth of a fungal pathogen, wherein said Methylobacterium strain is at a titer of at least 5×10 7 colony-forming units per gram for a dry composition, or at least 5×10 7 colony-forming units per milliliter for a liquid composition.

9 . The method of claim 8 wherein at least 10 3 CFU of said Methylobacterium strain are applied to said plant or plant part.

10 . The method of claim 8 wherein said plant part is a seed.

11 . The method of claim 8 wherein said plant is a leguminous or cereal crop plant.

12 . The method of claim 8 wherein said plant is selected from the group consisting of a rice, soybean, peanut, tomato, wheat, corn, barley, millet, sorghum, oat, and rye plant.

13 . The method of claim 8 wherein said plant is selected from the group consisting of a coffee, coconut, pineapple, citrus, cocoa, tea, banana, avocado, fig, guava, mango, olive, papaya, cashew, macadamia, almond, sugar beet, sugarcane, lettuce, green bean, lima bean, pea, cucurbit, ornamental, conifer and turfgrass plant.

14 . The method of claim 8 wherein said composition further comprises an antifungal compound selected from the group consisting of an azole, dithiocarbamate, strobilurin, and benzimidazole.

15 . The method of claim 14 wherein said azole antifungal compound is ipconazole.

16 . The method of claim 8 wherein said composition further comprises a fungicide.

17 . The method of claim 8 wherein said fungal pathogen is selected from the group consisting of a Rhizoctonia sp., a Fusarium sp., a Pythium sp., a Septoria sp., a Cercospora sp., a Colletotrichum sp., a Puccinia sp., and a Sclerotinia sp.

18 . The method of claim 10 wherein said composition further comprises an agricultural polymer solution.

19 . The method of claim 8 wherein said composition further comprises Methylobacterium strain NLS0017 (NRRL B-50931) and/or NLS0020 (NRRL B-50930).

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2022
From: RIOUX, RENEE
To: NEWLEAF SYMBIOTICS, INC.
Reel/Frame 059171/0354 →
Continuity (3)
Continuation 15580208 · Jun 10, 2016
Provisional Application 62173789 · Jun 10, 2015
Related Publication 20220256862A1 · Aug 18, 2022
References Cited (72)
US 6014451A · Berry et al. · 2000 [cited by applicant]
US 6133196A · Ocamb et al. · 2000 [cited by applicant]
US 9181541B2 · Bogosian · 2015 [cited by applicant]
US 9845462B2 · Bogosian · 2017 [cited by applicant]
US 10098353B2 · Breakfield et al. · 2018 [cited by applicant]
US 10111438B2 · Floro et al. · 2018 [cited by applicant]
US 10212939B2 · Floro et al. · 2019 [cited by applicant]
US 10287544B2 · Bogosian · 2019 [cited by applicant]
US 10368547B2 · Floro et al. · 2019 [cited by applicant]
US 10448645B2 · Breakfield et al. · 2019 [cited by applicant]
US 10450556B2 · Bogosian · 2019 [cited by applicant]
US 10716307B2 · Breakfield et al. · 2020 [cited by applicant]
US 10757946B2 · Allen et al. · 2020 [cited by applicant]
US 10945440B2 · Didonato Floro · 2021 [cited by examiner]
US 11147276B2 · Floro · 2021 [cited by examiner]
US 11278029B2 · Rioux · 2022 [cited by examiner]
US 12016338B2 · Didonato Floro · 2024 [cited by examiner]
US 20080148432A1 · Abad · 2008 [cited by applicant]
US 20110053771A1 · Goodwin · 2011 [cited by applicant]
US 20140147425A1 · Henn et al. · 2014 [cited by applicant]
US 20150044327A1 · Feinberg · 2015 [cited by applicant]
US 20150337256A1 · Bogosian · 2015 [cited by applicant]
US 20160073641A1 · Allen et al. · 2016 [cited by applicant]
US 20160120188A1 · Bogosian · 2016 [cited by applicant]
US 20160295868A1 · Jones et al. · 2016 [cited by applicant]
US 20160302423A1 · Jones et al. · 2016 [cited by applicant]
US 20160302424A1 · DiDonato et al. · 2016 [cited by applicant]
US 20160302425A1 · DiDonato et al. · 2016 [cited by applicant]
US 20170086464A1 · Floro et al. · 2017 [cited by applicant]
US 20170135352A1 · Breakfield et al. · 2017 [cited by applicant]
US 20170164618A1 · Breakfield et al. · 2017 [cited by applicant]
US 20170238553A1 · Jones et al. · 2017 [cited by applicant]
US 20180142230A1 · Bogosian · 2018 [cited by applicant]
US 20180295841A1 · Rioux · 2018 [cited by applicant]
US 20190021334A1 · DiDonato Floro et al. · 2019 [cited by applicant]
US 20190116803A1 · DiDonato Floro et al. · 2019 [cited by applicant]
US 20190241865A1 · Bogosian · 2019 [cited by applicant]
US 20190297895A1 · Floro et al. · 2019 [cited by applicant]
US 20190364905A1 · Rioux et al. · 2019 [cited by applicant]
US 20200315181A1 · Breakfield et al. · 2020 [cited by applicant]
US 20200318095A1 · Bogosian · 2020 [cited by applicant]
CA 2183275A1 · 1998 [cited by applicant]
CN 101028008A · 2007 [cited by applicant]
CN 104508118A · 2015 [cited by applicant]
WO 2013181610A1 · 2013 [cited by applicant]
WO 2015085063A1 · 2015 [cited by applicant]
WO 2015085115A1 · 2015 [cited by applicant]
WO 2015085116A1 · 2015 [cited by applicant]
WO 2015085117A1 · 2015 [cited by applicant]
WO 2015142393A1 · 2015 [cited by applicant]
WO 2015200902A1 · 2015 [cited by applicant]
WO 2016069564A1 · 2016 [cited by applicant]
WO 2016201284A2 · 2016 [cited by applicant]
WO 2018106899A1 · 2018 [cited by applicant]
WO 2020117689A1 · 2020 [cited by applicant]
WO 2020117690A1 · 2020 [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/36968 dated Dec. 7, 2016. [cited by applicant]
Madhaiyan et al., “Growth Promotion and Induction of Systemic Resistance in Rice Cultivar Co-47 ( [cited by applicant]
Madhaiyan et al., “Pink Pigmented Facultative Methylotrophic Bacteria (PPFMs): Introduction to Current Concepts,” Korean J. Soil Sci. Fert., 2004, pp. 266-287, vol. 37, No. 4. [cited by applicant]
Madhaiyan et al., “Plant Growth-Promoting Methylobacterium Induces Defense Responses in Groundnut ( [cited by applicant]
Poornianunal et al., “In Vitro Biocontrol Activity ofMethylobacterium Extorquens Against Fungal Pathogens”, International Journal of Plant Protection, 2009, pp. 59-62, vol. 2, No. 1. [cited by applicant]
Savitha, “Studies on Pink Pigmented Facultative Methylotrophs of Major Chilli Growing Areas of North Karnataka”, Jun. 1, 2015, pp. 1-139, retrieved from: http://krishikosh.egranth.ac.in/bitstrearn/ 69836/1/thl 0680.pdf. [cited by applicant]
International Search Report and Written Opinion for PCT/US2017/065081 dated Mar. 12, 2018. [cited by applicant]
Menpara et al., “Endophytic Bacteria-Unexplored Reservoir of Antimicrobials for Combating Microbial Pathogens”, Microbial Pathogens and Strategies for Combating them: Science, Technology and Education, Dec. 1, 2013, pp.… [cited by applicant]
Nascimento et al., “Endophytic Bacteria from Piper Tuberculatum Jacq.: Isolation, Molecular Characterization, and in Vitro Screening for the Control of [cited by applicant]
Tani et al., “High-Throughput Identification and Screening of Novel [cited by applicant]
Ardanov et al., “Effects of [cited by applicant]
Extended European Search Report for EPI 7877804.9 dated Jun. 26, 2020. [cited by applicant]
Schlaeppi et al., “The Plant Microbiome at Work”, MPMI vol. 28, No. 3, 2015, pp. 217-217; http://dx.doi.org/10.1094/MPMI-10-14-0334-FI. [cited by applicant]
Tani et al. Supplemental Data S2 Table downloaded from http://doi.org./10.101371/journal.pone.012509.s005 on Nov. 20, 2020. [cited by applicant]
Tani et al. “ [cited by applicant]
International Search Report and Written Opinion issued in PCT/US2016/036968 dated Dec. 7, 2016. [cited by applicant]